Prof. Dr. med. Günter Emons

Name Card

Staff Status
unigoe
 

1-33 of 33
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2021 | Journal Article
    ​ ​Emons G, Kim, Jae-Weon, Weide K, de Gregorio N, Wimberger P, Trillsch F, et al. ​Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)​. ​​International Journal of Gynecologic Cancer. ​2021;​31​(7):​​1075​-1079​. ​doi:10.1136/ijgc-2021-002703. 
    ​Details  DOI 
  • 2021 | Journal Article | Research Paper | 
    ​ ​Gründker C, Emons G. ​Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer​. ​​Cells. ​2021;​10​(2):​​437​. ​doi:10.3390/cells10020437. 
    ​Details  DOI 
  • 2021 | Journal Article | 
    ​ ​Emons G, Gründker C. ​The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer​. ​​Cells. ​2021;​10​(2):​​292​. ​doi:10.3390/cells10020292. 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Ortmann O, Emons G, Tempfer C. ​S3-Leitlinie: Hormonersatztherapie und Krebsrisiko​. ​​Gynäkologische Endokrinologie. ​2020;. ​doi:10.1007/s10304-020-00309-y. 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Bergau PFL, Schirmer MA, Leha A, Leu M, Emons G, Hess CF, et al. ​The impact of rectal/bladder filling and applicator positioning on in vivo rectal dosimetry in vaginal cuff brachytherapy using an enhanced therapy setting​. ​​Brachytherapy. ​2020;​19​(2):​​168​-175​. ​doi:10.1016/j.brachy.2019.11.009. 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Kolb K, Hellinger J, Kansy M, Wegwitz F, Bauerschmitz G, Emons G, et al. ​Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer Cells​. ​​Cells. ​2020;​9​(12):​​2616​. ​doi:10.3390/cells9122616. 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Emons G. ​Comprehensive pelvic and paraaortic lymphadenectomy in patients with apparently early stage uterine serous carcinoma – an anachronism?​. ​​Journal of Gynecologic Oncology. ​2020;​31​(5). ​doi:10.3802/jgo.2020.31.e76. 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Läsche M, Emons G, Gründker C. ​Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death​. ​​Frontiers in Oncology. ​2020;​10​. ​doi:10.3389/fonc.2020.00409. 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Hellinger JW, Schömel F, Buse JV, Lenz C, Bauerschmitz G, Emons G, et al. ​Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling​. ​​Scientific Reports. ​2020;​10​(1). ​doi:10.1038/s41598-020-74838-8. 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Emons G, Mustea A, Tempfer C. ​Tamoxifen and Endometrial Cancer: A Janus-Headed Drug​. ​​Cancers. ​2020;​12​(9):​​2535​. ​doi:10.3390/cancers12092535. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Garcia-Etienne CA, Mansel RE, Tomatis M, Heil J, Biganzoli L, Ferrari A, et al. ​Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice​. ​​The Breast. ​2019;​45​:​​89​-96​. ​doi:10.1016/j.breast.2019.03.002. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Gründker C, Wokoun U, Hellriegel M, Emons G. ​Inhibition of aerobic glycolysis enhances the anti‐tumor efficacy of Zoptarelin Doxorubicin in triple‐negative breast cancer cells​. ​​The Journal of Obstetrics and Gynaecology Research. ​2019;​45​(7):​​1334​-1342​. ​doi:10.1111/jog.13980. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Gründker C, Läsche M, Hellinger J, Emons G. ​Mechanisms of Metastasis and Cell Mobility – The Role of Metabolism​. ​​Geburtshilfe und Frauenheilkunde. ​2019;​79​(02):​​184​-188​. ​doi:10.1055/a-0805-9113. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Ortmann O, Treeck O, Inwald EC, Emons G, Tempfer C. ​Hormonersatztherapie und Brustkrebsrisiko​. ​​Der Gynäkologe. ​2019;​52​(8):​​605​-616​. ​doi:10.1007/s00129-019-4472-0. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Ortmann O, Emons G, Tempfer C. ​S3-Leitlinie: Hormonersatztherapie und Krebsrisiko​. ​​Der Gynäkologe. ​2019;​53​(1):​​29​-34​. ​doi:10.1007/s00129-019-04504-2. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Vordermark D, Emons G. ​Strahlentherapie des Endometriumkarzinoms: S3-Leitlinie 2018 und neue Studiendaten​. ​​Der Gynäkologe. ​2019;​52​(12):​​910​-917​. ​doi:10.1007/s00129-019-04526-w. 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Emons G, Tempfer C, Battista MJ, Mustea A, Vordermark D. ​Adjuvant Radiotherapy and/or Chemotherapy for Endometrial Cancer, Status as at 2019​. ​​Geburtshilfe und Frauenheilkunde. ​2019;​79​(12):​​1273​-1277​. ​doi:10.1055/a-1019-7720. 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Hellinger JW, Hüchel S, Goetz L, Bauerschmitz G, Emons G, Gründker C. ​Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion​. ​​Frontiers in Oncology. ​2019;​9​. ​doi:10.3389/fonc.2019.01074. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Vordermark D, Emons G. ​Adjuvant treatment for endometrial cancer​. ​​Current Opinion in Oncology. ​2019;​31​(5):​​404​-410​. ​doi:10.1097/CCO.0000000000000558. 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Schmalfeldt B, Brambs C, Burges A, El-Balat A, Emons G, Fink D, et al. ​What is the evidence for lymphadenectomy in presumed early ovarian cancer?​. ​​Archives of Gynecology and Obstetrics. ​2018;​299​(1):​​1​-5​. ​doi:10.1007/s00404-018-4945-8. 
    ​Details  DOI 
  • 2018 | Journal Article | 
    ​ ​Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, et al. ​Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) – Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities​. ​​Geburtshilfe und Frauenheilkunde. ​2018;​78​(11):​​1089​-1109​. ​doi:10.1055/a-0715-2964. 
    ​Details  DOI 
  • 2018 | Journal Article | 
    ​ ​Emons G, Tempfer C, Battista M, Mustea A, Vordermark D. ​Statement of the Uterus Committee of the Gynaecological Oncology Working Group (AGO) on the PORTEC-3 study​. ​​Geburtshilfe und Frauenheilkunde. ​2018;​78​(10):​​923​-926​. ​doi:10.1055/a-0658-1918. 
    ​Details  DOI 
  • 2018 | Journal Article | 
    ​ ​Engel C, Rhiem K, Hahnen E, Loibl S, Weber KE, Seiler S, et al. ​Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history​. ​​BMC Cancer. ​2018;​18​(1). ​doi:10.1186/s12885-018-4029-y. 
    ​Details  DOI 
  • 2018 | Journal Article | 
    ​ ​Emons G, Steiner E, Vordermark D, Uleer C, Bock N, Paradies K, et al. ​Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) – Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer​. ​​Geburtshilfe und Frauenheilkunde. ​2018;​78​(10):​​949​-971​. ​doi:10.1055/a-0713-1218. 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Del Campo JM, Mirza MR, Berek JS, Provencher DM, Emons G, Fabbro M, et al. ​The successful phase 3 niraparib ENGOT-OV16/NOVA trial included a substantial number of patients with platinum resistant ovarian cancer (OC).​. ​​Journal of Clinical Oncology. ​2017;​35​(15_suppl):​​5560​-5560​. ​doi:10.1200/JCO.2017.35.15_suppl.5560. 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Wokoun U, Hellriegel M, Emons G, Gründker C. ​Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors​. ​​Oncology Reports. ​2017;​37​(4):​​2418​-2424​. ​doi:10.3892/or.2017.5491. 
    ​Details  DOI 
  • 2013 | Journal Article
    ​ ​Emons G, Günthert AR, Thiel FC, Camara O, Strauss, Hans-Georg, Breitbach, Georg-Peter, et al. ​Phase II study of fulvestrant 250 mg/month in patients with recurrent or metastatic endometrial cancer: A study of the Arbeitsgemeinschaft Gynakologische Onkologie​. ​​Gynecologic Oncology. ​2013;​129​(3):​​495​-499​. ​doi:10.1016/j.ygyno.2013.02.039. 
    ​Details  DOI  PMID  PMC  WoS 
  • 2009 | Conference Abstract
    ​ ​Gruendker C, Peick D, Fister S, Emons G. ​Combination therapy with a GnRH-II Antagonist, and 4OH-Tamoxifen for the treatment of human breast cancer cells​. ​​Geburtshilfe und Frauenheilkunde. ​2009;​69​(8)
    ​Details  WoS 
  • 2009 | Conference Abstract
    ​ ​Hawighorst T, Hussein F, Gruendker C, Emons G. ​Thrombospondin-2 inhibits Angiogenesis via a CD 36 receptor-dependent induction of Endothelial apoptoze​. ​​Geburtshilfe und Frauenheilkunde. ​2009;​69​(8):744​-745​. ​
    ​Details  WoS 
  • 2009 | Journal Article | 
    ​ ​Girgert R, Hanf V, Emons G, Gruendker C. ​Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells​. ​​Journal of Pineal Research. ​2009;​47​(1):​​23​-31​. ​doi:10.1111/j.1600-079X.2009.00684.x. 
    ​Details  DOI  PMID  PMC  WoS 
  • 2008 | Journal Article
    ​ ​Fister S, Schlotawa L, Gunthert AR, Emons G, Gründker C. ​Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells​. ​​Gynecological Endocrinology. ​2008;​24​(1):​​24​-29​. ​doi:10.1080/09513590701668882. 
    ​Details  DOI  PMID  PMC  WoS 
  • 2007 | Journal Article
    ​ ​Harms L, Emons G, Bader W, Lange R, Hilgers R, Viereck V. ​Funneling before and after anti-incontinence surgery - a prognostic indicator? Part 2: tension-free vaginal tape​. ​​International Urogynecology Journal. ​2007;​18​(3):​​289​-294​. ​doi:10.1007/s00192-006-0147-1. 
    ​Details  DOI  PMID  PMC  WoS 
  • 2006 | Journal Article
    ​ ​von Alten J, Fister S, Schulz H, Viereck V, Frosch, Karl-Heinz, Emons G, et al. ​GnRH analogs reduce invasiveness of human breast cancer cells​. ​​Breast Cancer Research and Treatment. ​2006;​100​(1):​​13​-21​. ​doi:10.1007/s10549-006-9222-z. 
    ​Details  DOI  PMID  PMC  WoS 

Publication List

All Articles (Book & Journal) Conference objects Articles & Preprints Papers (Journal & Conference)

Type

Subtype

Date issued

Author

Peer-Reviewed

Organization

Language

Fulltext

Options

Citation Style

GRO View APA Chicago MLA Vancouver
https://publications.goettingen-research-online.de URI: /cris/rp/rp34134
ID: 0000000
PREF: vancouver TOKEN:

0

Sort

Issue Date
ASC DESC
Title
ASC DESC

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.